光声成像（PAI），也被称为光声成像，已在从炎症性疾病到癌症的各种应用中在早期临床试验中显示出前景。虽然最近第一批PAI系统已获得监管批准，但将PAI技术成功应用于临床决策的医疗保健系统仍需克服一系列障碍，包括教育培训、数据采集和解释等。国际光声标准化协会（IPASC）于2022年进行了一项社区活动，以确定和理解这些障碍，然后制定战略计划的路线图来解决这些障碍。在这里，我们概述了被识别出的障碍的性质和范围，并提出了在短期、中期和长期内克服这些障碍所需的社区努力，无论是IPASC团队内还是团队外。© 2023 Elsevier GmbH出版。

Photoacoustic imaging (PAI), also referred to as optoacoustic imaging, has shown promise in early-stage clinical trials in a range of applications from inflammatory diseases to cancer. While the first PAI systems have recently received regulatory approvals, successful adoption of PAI technology into healthcare systems for clinical decision making must still overcome a range of barriers, from education and training to data acquisition and interpretation. The International Photoacoustic Standardisation Consortium (IPASC) undertook an community exercise in 2022 to identify and understand these barriers, then develop a roadmap of strategic plans to address them. Here, we outline the nature and scope of the barriers that were identified, along with short-, medium- and long-term community efforts required to overcome them, both within and beyond the IPASC group.© 2023 Published by Elsevier GmbH.